MARKET NEWS

Provectus Biopharmaceuticals Announces Synthesis of New Halogenated Xanthene Small Molecule
4D pharma Announces Positive Interim Results From Phase 1/2 Study 
Rani Therapeutics Announces Initiation of Phase 1 Study for Osteoporosis
Viridian Therapeutics Doses First Subject in First-in-Human Clinical Trial Evaluating a Next- Generation IGF-1R Antibody
Blue Water Vaccines Announces Publication in Nano Research Supporting Novel S&P Vaccine Platform Versatility
Vallon Pharmaceuticals Announces Topline Results of its Pivotal SEAL Study for Lead Program

  FEATURED EDITORIAL

  COMPANY PROFILE

Eurofins BioPharma Product Testing offers complete CMC Testing Services for the Bio/Pharmaceutical industry, including all starting materials, process intermediates, drug substances, drug product, packaging, and manufacturing support through our broad technical expertise in Biochemistry, Molecular & Cell Biology, Virology, Chemistry, and Microbiology. With a global capacity of more than 2,000,000 square feet of facilities and 37 locations worldwide, our network of GMP laboratories and vast experience allow us to support projects of any size from conception to market. Click here for more.


Video Spotlight: MilliporeSigma (Ready-to-Use Buffers)

  EXCLUSIVE ONLINE CONTENT

DFE Pharma, Harro Höfliger & Sterling Announce Unique Partnership to Provide Formulation Services for Respiratory Products

DFE Pharma, Harro Höfliger & Sterling Announce Unique Partnership to Provide Formulation Services for Respiratory Products

Three leading companies in their respective fields – DFE Pharma (excipients solution provider), Harro Höfliger (equipment supplier), and Sterling (API manufacturer) recently announced a unique partnership….

Gerresheimer Opens a New Plant to Produce Pharmaceutical Container Solutions

Gerresheimer Opens a New Plant to Produce Pharmaceutical Container Solutions

Gerresheimer ceremoniously took over a new building in Berlin, Ohio. In the future, the square plastic containers of the Duma Twist-Off Q brand with a 40-ml filling volume….

GeoVax Announces Issuance of Cancer Vaccine Patent

GeoVax Announces Issuance of Cancer Vaccine Patent

GeoVax Labs, Inc. recently announced the U.S. Patent and Trademark Office has issued Patent No. 11278607 to GeoVax, pursuant to the company’s patent application No. 16/068,527 titled….

Jeune Aesthetics Announces Positive Clinical Phase 1 Efficacy Results for Investigational Gene-Based Treatment to Address the Underlying Biology of Aging Skin

Jeune Aesthetics Announces Positive Clinical Phase 1 Efficacy Results for Investigational Gene-Based Treatment to Address the Underlying Biology of Aging Skin

Jeune Aesthetics, Inc., a wholly owned subsidiary of Krystal Biotech, Inc., recently announced positive proof-of-concept efficacy data from Cohort 2 of the PEARL-1 study of KB301….

Lonza Partners With Oasmia Pharmaceuticals to Manufacture Ovarian Cancer Therapy

Lonza Partners With Oasmia Pharmaceuticals to Manufacture Ovarian Cancer Therapy

Oasmia Pharmaceutical AB and Lonza recently announced the companies have signed a large-scale manufacturing agreement for the main drug intermediate in the supply of….

  WHITEPAPERS & WEBINARS

Where Do We Stand on Poorly Soluble Drugs and Peptides in Oral Delivery?

Where Do We Stand on Poorly Soluble Drugs and Peptides in Oral Delivery?

The Rule of 5 suggests that, for oral bioavailability, a better chance for oral absorption is obtained when the molecules are within the parameters of the Rule of 5’. However, the pharmaceutical industry is achieving oral efficacy with drugs that exceed….

Bespak by Recipharm Webinar: Learn How To Overcome Viscous Formulation Challenges For Parenteral Delivery

Bespak by Recipharm Webinar: Learn How To Overcome Viscous Formulation Challenges For Parenteral Delivery

There have been many challenges holding back widespread adoption of self-administered injectable formulations. One of the most pressing is the need to develop an auto-injector with a fine enough needle for….

  WHITEPAPERS & WEBINARS

WHITE PAPER: Tackling a Changing Climate; Metered Dose Inhalers | Recipharm

WHITE PAPER: Tackling a Changing Climate; Metered Dose Inhalers | Recipharm

Are you prepared for the HFA phasedown? With many industries switching to more environmentally friendly propellants, pMDI developers need to be ready. Recipharm explore alternative technologies to HFA propellants, and how the devices and formulations can be optimized to ensure …

WHITE PAPER - A Safe & Efficient Analytical Method for Identity Determination of Oligonucleotides is Now Available     

WHITE PAPER - A Safe & Efficient Analytical Method for Identity Determination of Oligonucleotides is Now Available     

By: Alexandra H. Heussner, PhD, Laboratory Manager ASL, and Melanie Zerulla-Wernitz, PhD, Head of ASL, Development Service, Vetter Pharma-Fertigung GmbH & Co. KG

In the pharmaceutical manufacturing process, a relatively new class of parenteral drug products on the market – …

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

April 6 – Excipients
April 13 – Prefilled Syringes